Department of Pediatrics and Gastroenterology, University of Kentucky, Lexington, KY, USA; Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, KY, USA; Saha Cardiovascular Research Center, University of Kentucky, Lexington, KY, USA; Markey Cancer Center, University of Kentucky, Lexington, KY, USA.
Department of Pediatrics and Gastroenterology, University of Kentucky, Lexington, KY, USA; Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, KY, USA.
J Hepatol. 2023 Jul;79(1):25-42. doi: 10.1016/j.jhep.2023.02.010. Epub 2023 Feb 21.
BACKGROUND & AIMS: The consumption of sugar and a high-fat diet (HFD) promotes the development of obesity and metabolic dysfunction. Despite their well-known synergy, the mechanisms by which sugar worsens the outcomes associated with a HFD are largely elusive.
Six-week-old, male, C57Bl/6 J mice were fed either chow or a HFD and were provided with regular, fructose- or glucose-sweetened water. Moreover, cultured AML12 hepatocytes were engineered to overexpress ketohexokinase-C (KHK-C) using a lentivirus vector, while CRISPR-Cas9 was used to knockdown CPT1α. The cell culture experiments were complemented with in vivo studies using mice with hepatic overexpression of KHK-C and in mice with liver-specific CPT1α knockout. We used comprehensive metabolomics, electron microscopy, mitochondrial substrate phenotyping, proteomics and acetylome analysis to investigate underlying mechanisms.
Fructose supplementation in mice fed normal chow and fructose or glucose supplementation in mice fed a HFD increase KHK-C, an enzyme that catalyzes the first step of fructolysis. Elevated KHK-C is associated with an increase in lipogenic proteins, such as ACLY, without affecting their mRNA expression. An increase in KHK-C also correlates with acetylation of CPT1α at K508, and lower CPT1α protein in vivo. In vitro, KHK-C overexpression lowers CPT1α and increases triglyceride accumulation. The effects of KHK-C are, in part, replicated by a knockdown of CPT1α. An increase in KHK-C correlates negatively with CPT1α protein levels in mice fed sugar and a HFD, but also in genetically obese db/db and lipodystrophic FIRKO mice. Mechanistically, overexpression of KHK-C in vitro increases global protein acetylation and decreases levels of the major cytoplasmic deacetylase, SIRT2.
KHK-C-induced acetylation is a novel mechanism by which dietary fructose augments lipogenesis and decreases fatty acid oxidation to promote the development of metabolic complications.
Fructose is a highly lipogenic nutrient whose negative consequences have been largely attributed to increased de novo lipogenesis. Herein, we show that fructose upregulates ketohexokinase, which in turn modifies global protein acetylation, including acetylation of CPT1a, to decrease fatty acid oxidation. Our findings broaden the impact of dietary sugar beyond its lipogenic role and have implications on drug development aimed at reducing the harmful effects attributed to sugar metabolism.
糖和高脂肪饮食(HFD)的摄入会促进肥胖和代谢功能障碍的发展。尽管它们的协同作用众所周知,但糖加剧与 HFD 相关的后果的机制在很大程度上仍难以捉摸。
将 6 周龄雄性 C57Bl/6J 小鼠分别喂食标准饲料或 HFD,并提供常规、果糖或葡萄糖甜味水。此外,使用慢病毒载体工程改造 AML12 肝细胞以过表达酮己糖激酶-C(KHK-C),同时使用 CRISPR-Cas9 敲低 CPT1α。细胞培养实验补充了使用过表达 KHK-C 的肝特异性 CPT1α 敲除小鼠的体内研究。我们使用综合代谢组学、电子显微镜、线粒体底物表型、蛋白质组学和乙酰基组分析来研究潜在机制。
在正常饲料中添加果糖以及在 HFD 中添加果糖或葡萄糖都会增加 KHK-C,这是一种催化果糖分解第一步的酶。升高的 KHK-C 与脂肪生成蛋白(如 ACLY)的增加有关,而不影响其 mRNA 表达。KHK-C 的增加还与 CPT1α 在 K508 处的乙酰化以及体内 CPT1α 蛋白的降低相关。在体外,KHK-C 的过表达会降低 CPT1α 并增加甘油三酯的积累。CPT1α 的敲低部分复制了 KHK-C 的作用。在喂食糖和 HFD 的小鼠中,KHK-C 的增加与 CPT1α 蛋白水平呈负相关,但在遗传性肥胖 db/db 和脂肪营养不良 FIRKO 小鼠中也是如此。机制上,体外过表达 KHK-C 会增加整体蛋白质乙酰化并降低主要细胞质去乙酰化酶 SIRT2 的水平。
KHK-C 诱导的乙酰化是膳食果糖增强脂肪生成和减少脂肪酸氧化以促进代谢并发症发展的新机制。
果糖是一种高度致脂的营养素,其负面影响主要归因于从头脂肪生成增加。在此,我们表明果糖上调 ketohexokinase,这反过来又修饰了包括 CPT1a 在内的全局蛋白质乙酰化,以减少脂肪酸氧化。我们的发现拓宽了饮食糖的影响范围,超越了其致脂作用,并对旨在减少归因于糖代谢的有害影响的药物开发具有重要意义。